Bemrist Breezhaler
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Bemrist Breezhaler, covering 2025-10-07 to 2025-10-07. Get the full timeline:
Most recent: EMA Authorised: Bemrist Breezhaler (indacaterol;mometasone furoate) — Novartis Europharm Limited